Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CardioTech International, Inc.
FDA clears heparin-coated cardiopulmonary bypass blood reservoir
April 26th, 2005
CardioTech International, Inc., (CTE) announced that its wholly owned subsidiary, Gish Biomedical, Inc., (Gish) has received U.S. Food and Drug Administration (FDA) clearance to sell a disposable soft-shell venous reservoir that facilitates air removal during surgical procedures requiring extracorporeal support for up to 6 hours. The worldwide cardiopulmonary bypass market is estimated to be about $500 million annually. Gish received FDA clearance to market the Circulatory Technology, Inc., V-BAG vacuum-assisted soft-shell venous reservoir with Gish's proprietary GBS heparin coating on March 17, 2005. The use of vacuum-assisted venous drainage is...
Source: Cardiovascular Business Week (2005-04-26)
|
